$9.90
-4.4%Phreesia, Inc. provides an integrated SaaS-based software and payment platform for the healthcare industry in the United States and Canada. Its Phreesia Platform offers a suite of solutions to manage the patient intake process, as well as an integrated payments solution for processing of patient payments. The company deploys its platform in a range of modalities, such as Phreesia Mobile, a patients' mobile device; Phreesia Dashboard, a web-based dashboard for healthcare services clients; PhreesiaPads, which are self-service intake tablets; and Arrivals Kiosks that are on-site kiosks. Its Phreesia Platform also provides a registration solution to automate patient self-registration; revenue cycle solution, which offer insurance-verification processes, point-of-sale payments applications, and cost estimation tools; access solutions that offers appointment scheduling system for online appointments, reminders, and referral tracking; and life sciences solution to deliver targeted and clinically relevant marketing content to patients. In addition, the company's Phreesia Platform offers clinical support solution, which collects clinical intake and patient reported outcome (PRO) data for approximately 25 specialties, as well as enables healthcare services clients to communicate with their patients through surveys, announcements, text and email messaging, and health campaigns; and COVID-19 support modules for managing COVID-19 vaccine delivery and identify vaccine-hesitant patients, screening for self-reported COVID-19 risk factors, enabling contactless check-in during in-person visits, and collecting intake information during telehealth visits. It serves patients; single-specialty practices, multi-specialty groups, and health systems; and pharmaceutical, medical device, and biotechnology companies. The company was incorporated in 2005 and is headquartered in Raleigh, North Carolina.
Last Annual Value
2.66M
3-Year CAGR
121%
5-Year CAGR
-11%
10-Year CAGR
9%
| Company | Short Term Debt | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
![]() Phreesia, Inc. NYSE:PHR | 2.66M | 121.0% | -11.4% | N/A | |
![]() BioLife Solutions, Inc. NASDAQ:BLFS | 5.00M | -7.4% | 42.1% | N/A | |
![]() Schrödinger, Inc. NASDAQ:SDGR | 16.41M | N/A | N/A | N/A | |
![]() NovoCure Limited NASDAQ:NVCR | 11.66M | N/A | 11.8% | N/A | |
![]() GoodRx Holdings, Inc. NASDAQ:GDRX | 9.75M | 3.5% | 6.8% | N/A | |
![]() Omada Health NASDAQ:OMDA | 0.00 | N/A | N/A | N/A | |
![]() Kestra Medical Technologies, Ltd. NASDAQ:KMTS | 187.00K | -79.1% | N/A | N/A | |
![]() Omnicell, Inc. NASDAQ:OMCL | 11.96M | N/A | -52.4% | 3.6% | |
![]() Neogen Corporation NASDAQ:NEOG | 19.30M | 80.6% | 71.9% | N/A | |
![]() Teladoc Health, Inc. NYSE:TDOC | 11.04M | N/A | N/A | 18.6% |
Continue your PHR research with focused valuation guides.
Snapshot
Start with context, operating signals, and key market metrics.
Value Model
Stress test fair value across bear, base, and bull assumptions.
Statements
Validate revenue quality, margins, and balance sheet durability.
Earnings Call
Read management commentary and compare it with reported outcomes.
Dividends
Check payout sustainability and long-term distribution behavior.
Analyst Expectations
Review consensus spread and where estimate risk is concentrated.